CLINICAL ENDOCRINOLOGY, vol.39, no.2, pp.151-155, 1993 (SCI-Expanded)
OBJECTIVE We determined the 17-hydroxyprogesterone (17-OH P) response to buserelin, a GnRH agonist, and its relation to ovarian volume in the patients with polycystic ovary syndrome (PCOS).